Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Comprehensive Versa-Dial Reverse Titanium (Ti) Glenosphere in Primary, Fracture and Revision Total Shoulder Arthroplasty

NCT04003272 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT04003272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04003272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Comprehensive Versa-Dial Reverse Titanium (Ti) Glenosphere in Primary, Fracture and Revision Total Shoulder Arthroplasty
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 28, 2019
Completion date
September 1, 2035
Enrollment
59 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

shoulder arthritis, shoulder disease, shoulder fractures, shoulder injuries, shoulder pain